Home/Kazia Therapeutics/Dr. John Friend
DJ

Dr. John Friend

Chief Executive Officer

Kazia Therapeutics

Therapeutic Areas

Kazia Therapeutics Pipeline

DrugIndicationPhase
PaxalisibGlioblastoma (GBM)Phase II/III
EVT801Advanced Solid TumorsPhase I